Sumanta K. Pal, MD, on Renal Cancer Immunotherapy: Latest Developments

2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Tweet this page

Sumanta K. Pal, MD, of the City of Hope, discusses immunotherapy as a front-line treatment for kidney cancer and the strategy of VEGF blockade with immunotherapy, which is emerging as a possible treatment modality.

Advertisement

Advertisement



Advertisement